Physician profile
Michael Shindle
NPI 1952578627
$1,386.60
in general payments reported to CMS, 2019-2025
14 companies · $223 in 2025
The $223 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2023: $408 · 2024: $523 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,154.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $358.83 | 2019-2024 | Monovisc, Orthovisc |
| Ferring Pharmaceuticals INC. | $214.40 | 2019-2025 | Euflexxa |
| Miach Orthopaedics, INC. | $189.25 | 2024 | |
| Smith+Nephew, INC. | $157.49 | 2023-2024 | Na, Goflo Pump, Clancy |
| Spinal Elements, INC. | $137.46 | 2025 | |
| Zimmer Biomet Holdings, INC. | $64.99 | 2023 | Quattro |
| Kowa Pharmaceuticals America, INC. | $59.08 | 2023 | Seglentis |
| Ibsa Pharma INC. | $58.50 | 2023-2024 | Tirosint, Licart, Licart |
| Djo, LLC | $43.52 | 2024 | Cmf |
| Alphatec Spine, INC | $27.65 | 2024 | Identiti |
| Electronic Waveform Lab, INC. | $26.81 | 2024 | |
| Fidia Pharma USA INC. | $25.16 | 2023 | Hymovis |
| Ossur Americas, INC. | $23.46 | 2025 | Unloader One X |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$980,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Shindle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.